Advisory Research’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Hold |
257,225
| – | – | 0.03% | 139 |
|
|
2025
Q1 | $234K | Hold |
257,225
| – | – | 0.04% | 142 |
|
|
2024
Q4 | $280K | Hold |
257,225
| – | – | 0.05% | 143 |
|
|
2024
Q3 | $195K | Hold |
257,225
| – | – | 0.03% | 153 |
|
|
2024
Q2 | $319K | Hold |
257,225
| – | – | 0.06% | 146 |
|
|
2024
Q1 | $486K | Hold |
257,225
| – | – | 0.1% | 131 |
|
|
2023
Q4 | $679K | Hold |
257,225
| – | – | 0.1% | 202 |
|
|
2023
Q3 | $592K | Hold |
257,225
| – | – | 0.08% | 253 |
|
|
2023
Q2 | $939K | Hold |
257,225
| – | – | 0.12% | 211 |
|
|
2023
Q1 | $918K | Hold |
257,225
| – | – | 0.15% | 167 |
|
|
2022
Q4 | $733K | Hold |
257,225
| – | – | 0.07% | 195 |
|
|
2022
Q3 | $574K | Hold |
257,225
| – | – | 0.06% | 222 |
|
|
2022
Q2 | $640K | Hold |
257,225
| – | – | 0.06% | 196 |
|
|
2022
Q1 | $1.26M | Hold |
257,225
| – | – | 0.1% | 163 |
|
|
2021
Q4 | $2.91M | Buy |
257,225
+1,225
| +0.5% | +$13.9K | 0.23% | 79 |
|
|
2021
Q3 | $3.73M | Hold |
256,000
| – | – | 0.24% | 98 |
|
|
2021
Q2 | $2.98M | Hold |
256,000
| – | – | 0.2% | 109 |
|
|
2021
Q1 | $3.12M | Buy |
+256,000
| New | +$3.12M | 0.22% | 104 |
|